Oruka Therapeutics SVP Finance Arjun Agarwal disposes of 9,999 common shares worth $1,067,833.92

• Oruka Therapeutics SVP, Finance Arjun Agarwal exercised employee stock options to acquire 10,000 common shares on Aug. 13.
• Same day, Agarwal sold 10,000 common shares in multiple trades at weighted-average prices ranging from $104.67 to $108.46.
• Directly held common shares ended at 15,312.
• Employee stock options beneficially owned ended at 59,792 and 92,917, with expirations in 2036 and 2035.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000075), on August 14, 2026, and is solely responsible for the information contained therein.